Manuel also translated his findings to the cancer context and demonstrated that high ZEB1 expression can prevent osteogenesis in osteosarcoma cells and eventually lock the tumor cells in an aggressive, undifferentiated state (Hu et al., 2011), indicating that ZEB1 may maintain the stemness of stem cells in both physiological and pathophysiological conditions. Here, ZEB1 is linked to cancer.